abiraterone
Showing 1 - 25 of 447
Prostate Cancer Trial in Chicago (Docetaxel, ADT, Abiraterone)
Not yet recruiting
- Prostate Cancer
- Docetaxel
- +2 more
-
Chicago, IllinoisNorthwestern University
Sep 27, 2023
Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)
Not yet recruiting
- Metastatic Hormone-Sensitive Prostate Cancer
- Rezvilutamide
- +2 more
- (no location specified)
Nov 10, 2023
Medicines Called Enzalutamide and Abiraterone in People With
Not yet recruiting
- Prostatic Neoplasms, Castration-Resistant
- Enzalutamide
- Abiraterone acetate
-
New York, New YorkPfizer Inc
Jul 21, 2023
Prostate Cancer Trial in Tampa (Abiraterone Acetate)
Active, not recruiting
- Prostate Cancer
- Abiraterone Acetate
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 3, 2023
High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) Trial (dalpiciclib isethionate tablets; abiraterone acetate
Not yet recruiting
- High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
- dalpiciclib isethionate tablets; abiraterone acetate tablets; prednisone tablets
- placebo; abiraterone acetate tablets; prednisone tablets
- (no location specified)
Oct 20, 2023
Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)
Recruiting
- Prostate Cancer
- Prostate Cancer Metastatic
- Abivertinib
- Abiraterone
-
La Jolla, California
- +1 more
Feb 2, 2023
Prostatic Tumors Trial in Bronx (Abiraterone Acetate, Prednisone)
Active, not recruiting
- Prostatic Neoplasms
- Abiraterone Acetate
- Prednisone
-
Bronx, New YorkMontefiore Medical Center
Sep 22, 2022
Prostate Cancer Trial (Neoadjuvant treatment)
Not yet recruiting
- Prostate Cancer
- Neoadjuvant treatment
- (no location specified)
Oct 19, 2022
High-risk Prostate Cancer, Neoadjuvant Therapy Trial in Shanghai (Abiraterone acetate, Fluzoparib, Prednisone)
Recruiting
- High-risk Prostate Cancer
- Neoadjuvant Therapy
- Abiraterone acetate
- +4 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 6, 2022
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,
Active, not recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- Abiraterone Acetate
- +2 more
-
Los Angeles, California
- +6 more
Jan 18, 2023
Metastatic Castration-resistant Prostate Cancer Trial (Niraparib plus Abiraterone Acetate (Nira/AA) combination,
Available
- Metastatic Castration-resistant Prostate Cancer
- Niraparib plus Abiraterone Acetate (Nira/AA) combination
- Prednisone/Prednisolone
- (no location specified)
Aug 24, 2022
Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Enzalutamide 40 MG, Docetaxel injection)
Not yet recruiting
- Prostate Cancer
- Castrate Resistant Prostate Cancer
- Enzalutamide 40 MG
- Docetaxel injection
- (no location specified)
Jan 27, 2023
Abiraterone Acetate in Indian Metastatic, Castration Resistant
Withdrawn
- Prostate Cancer
- Abiraterone Acetate
-
Bangalore, India
- +2 more
Aug 15, 2022
Prostate Cancer Trial in United States (Abiraterone Acetate, Prednisone 5Mg Tab, DST-2970 (Abiraterone))
Active, not recruiting
- Prostate Cancer
- Abiraterone Acetate
- +2 more
-
Miami, Florida
- +4 more
Dec 14, 2022
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Prostatic Neoplasms
- MK-5684
- +6 more
- (no location specified)
Nov 21, 2023
Prostate Cancer Castration-resistant Prostate Cancer Trial in Changsha (Abiraterone+SHR3162)
Active, not recruiting
- Prostate Cancer Castration-resistant Prostate Cancer
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Jul 6, 2022
Prostate Cancer Trial in Nanjing (Abiraterone Acetate, Prednisone, Goserelin 10.8 mg)
Active, not recruiting
- Prostate Cancer
- Abiraterone Acetate
- +2 more
-
Nanjing, Jiangsu, ChinaDepartment of Urology, Drum Tower Hospital, Medical School of Na
Dec 14, 2022
Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)
Recruiting
- Prostate Cancer Metastatic
- Prostate Cancer
- Abiraterone Acetate
- Prednisone
-
Houston, Texas
- +2 more
Oct 7, 2022
High-Risk Prostate Cancer Trial in Portland (Capivasertib, abiraterone acetate)
Not yet recruiting
- High-Risk Prostate Cancer
- Capivasertib
- abiraterone acetate
-
Portland, OregonVA Portland Health Care System, Portland, OR
Jan 17, 2023